Product Description
Fulvestrant injection is a vital component in the treatment regimen for postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer. As a selective estrogen receptor degrader (SERD), fulvestrant works by blocking and degrading estrogen receptors, thereby inhibiting tumor growth. Administered via injection, this medication offers an effective and well-tolerated option for women facing the challenges of advanced breast cancer. With its targeted approach and proven efficacy, Fulvestrant Injection plays a crucial role in improving outcomes and enhancing the quality of life for patients battling this disease.
Reliable Hormonal Therapy for Advanced Breast CancerFulvestrant Injection provides an effective treatment specifically for hormone receptor-positive metastatic breast cancer. As an estrogen receptor antagonist, it interrupts cancer cell growth by blocking hormonal pathways. Its design as a disposable pre-filled syringe ensures precise and convenient administration for healthcare providers, reducing preparation time and risk of dosing errors.
Convenient and Safe AdministrationPackaged in a sterile, single-use pre-filled syringe and containing no preservatives, Fulvestrant Injection supports safe and straightforward administration. The solution is clear, colorless or slightly yellow, and odorless, with a neutral pH suitable for intramuscular injection. Its ready-to-use format simplifies handling and ensures consistent delivery for oncology practitioners.
Strict Storage and Handling RequirementsTo preserve efficacy, Fulvestrant Injection must be stored refrigerated between 2C-8C and protected from light. Avoid freezing the product. The expiry date is printed on the packaging, and the shelf life is 24 months. Proper storage is essential for maintaining stability and safety during its use in clinical environments.
FAQ's of Fulvestrant Injection:
Q: How is Fulvestrant Injection administered?
A: Fulvestrant Injection is administered as an intramuscular (IM) injection using the pre-filled, disposable syringe by a qualified healthcare professional. It should never be given intravenously or via other routes.
Q: What is the main use of Fulvestrant Injection?
A: This product is indicated for the treatment of hormone receptor-positive metastatic breast cancer, serving as an estrogen receptor antagonist to inhibit tumor progression in affected patients.
Q: When should Fulvestrant Injection not be used?
A: Fulvestrant Injection is contraindicated in patients with known hypersensitivity to Fulvestrant or any of its excipients. It should only be used under medical supervision and according to prescription guidelines.
Q: Where should Fulvestrant Injection be stored?
A: Store Fulvestrant Injection in a refrigerator at 2C-8C. It must not be frozen and should be protected from light to maintain its efficacy. Always check the expiry date on the package before use.
Q: What are the benefits of using a pre-filled, single-use syringe for this medication?
A: The pre-filled, single-use syringe provides precise dosing, reduces preparation time, minimizes contamination risk, and enhances patient safety by eliminating the need for preservatives.
Q: Can Fulvestrant Injection be mixed with other drugs or solutions?
A: No, Fulvestrant Injection must not be mixed with any other drugs or solutions. It should be administered as provided, following the instructions on the packaging and by healthcare professionals.